SCHEMBL3849259

SCHEMBL3849259

CS(=O)(=O)Nc1ccc(CN2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
CYP1A2 P05177 3/20 0.55
CYP3A4 P08684 3/20 0.55
MAPK1 P28482 3/20 0.55
CLK4 Q9HAZ1 3/20 0.55
HIF1A Q16665 2/20 0.55
MEN1 O00255 1/20 0.55
ALDH1A1 P00352 1/20 0.55
KMT2A Q03164 1/20 0.55
USP2 O75604 2/20 0.54
AKT1 P31749 1/20 0.54
TNIK Q9UKE5 3/20 0.51
MET P08581 1/20 0.47
ACHE P22303 4/20 0.45
BACE1 P56817 4/20 0.45
AURKA O14965 1/20 0.44
RAF1 P04049 1/20 0.44
BRAF P15056 1/20 0.44
JAK2 O60674 2/20 0.43
HTT P42858 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3847274 0.88 AKT1 (0.55) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3854138 0.84 AKT1 (0.56) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3845918 0.84 CLK4 (0.54) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3847360 0.84 ACHE (0.59) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3846420 0.82 CYP1A2 (0.54) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL30734139 0.81 ACHE (0.56) LMNAMEN1KMT2AAKT1ACHE
SCHEMBL3852063 0.78 HTT (0.68) LMNACYP1A2CYP3A4MAPK1CLK4
Trifluoroacetic Acid SCHEMBL3855041 0.77 CYP1A2 (0.58) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3850109 0.76 CYP3A4 (0.65) LMNACYP1A2CYP3A4MAPK1CLK4
SCHEMBL3848425 0.76 ENPP1 (0.52) LMNACYP1A2CYP3A4MAPK1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed